|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/55 | |
| A61K 31/573 | |||
| A61K 9/00 | |||
| A61K 9/12 | |||
| A61M 11/04 | |||
| A61M 11/06 | |||
| A61M 15/00 | |||
| A61M 15/08 | |||
| A61P 27/14 |
| (11) | Patento numeris | 2788001 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12797884.9 |
| Europos patento paraiškos padavimo data | 2012-12-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-12-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/074374 |
| Data | 2012-12-04 |
| (87) | Numeris | WO 2013/083569 |
| Data | 2013-06-13 |
| (30) | Numeris | Data | Šalis |
| 201161567893 P | 2011-12-07 | US | |
| 201121812 | 2011-12-19 | GB |
| (72) |
ZENG, Xian-Ming, US
LY, Jade Ching-Ying, US
DALVI, Mukul C, US
|
| (73) |
Teva Branded Pharmaceutical Products R & D, Inc.,
41 Moores Road, Frazer, Pennsylvania 19355,
US
|
| (54) | NASAL FORMULATION |
| NASAL FORMULATION |